Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Skeletal Muscle Abnormalities and Iron Deficiency in Chronic Heart FailureAn Exercise 31P Magnetic Resonance Spectroscopy Study of Calf Muscle

V. Melenovsky, K. Hlavata, P. Sedivy, M. Dezortova, BA. Borlaug, J. Petrak, J. Kautzner, M. Hajek,

. 2018 ; 11 (9) : e004800. [pub] -

Language English Country United States

Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc19034948

Grant support
R01 HL128526 National Heart, Lung, and Blood Institute - United States
R01 HL126638 National Heart, Lung, and Blood Institute - United States
U01 HL125205 National Heart, Lung, and Blood Institute - United States
U10 HL110262 National Heart, Lung, and Blood Institute - United States
NV16-27496A MZ0 CEP Register

BACKGROUND: Heart failure (HF) is often associated with iron deficiency (ID). Skeletal muscle abnormalities are common in HF, but the potential role of ID in this phenomenon is unclear. In addition to hemopoiesis, iron is essential for muscle bioenergetics. We examined whether energetic abnormalities in skeletal muscle in HF are affected by ID and if they are responsive to intravenous iron. METHODS AND RESULTS: Forty-four chronic HF subjects and 25 similar healthy volunteers underwent 31P magnetic resonance spectroscopy of calf muscle at rest and during exercise (plantar flexions). Results were compared between HF subjects with or without ID. In 13 ID-HF subjects, examinations were repeated 1 month after intravenous ferric carboxymaltose administration (1000 mg). As compared with controls, HF subjects displayed lower resting high-energy phosphate content, lower exercise pH, and slower postexercise PCr recovery. Compared with non-ID HF, ID-HF subjects had lower muscle strength, larger PCr depletion, and more profound intracellular acidosis with exercise, consistent with an earlier metabolic shift to anaerobic glycolysis. The exercise-induced PCr drop strongly correlated with pH change in HF group ( r=-0.71, P<0.001) but not in controls ( r=0.13, P=0.61, interaction: P<0.0001). Short-term iron administration corrected the iron deficit but had no effect on muscle bioenergetics assessed 1 month later. CONCLUSIONS: HF patients display skeletal muscle myopathy that is more severe in those with iron deficiency. The presence of ID is associated with greater acidosis with exercise, which may explain early muscle fatigue. Further study is warranted to identify the strategy to restore iron content in skeletal muscle.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19034948
003      
CZ-PrNML
005      
20191014095610.0
007      
ta
008      
191007s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1161/CIRCHEARTFAILURE.117.004800 $2 doi
035    __
$a (PubMed)30354361
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Melenovsky, Vojtech $u Department of Cardiology, Institute for Clinical and Experimental Medicine, IKEM, Prague, Czech Republic (V.M., K.H., J.K.).
245    10
$a Skeletal Muscle Abnormalities and Iron Deficiency in Chronic Heart FailureAn Exercise 31P Magnetic Resonance Spectroscopy Study of Calf Muscle / $c V. Melenovsky, K. Hlavata, P. Sedivy, M. Dezortova, BA. Borlaug, J. Petrak, J. Kautzner, M. Hajek,
520    9_
$a BACKGROUND: Heart failure (HF) is often associated with iron deficiency (ID). Skeletal muscle abnormalities are common in HF, but the potential role of ID in this phenomenon is unclear. In addition to hemopoiesis, iron is essential for muscle bioenergetics. We examined whether energetic abnormalities in skeletal muscle in HF are affected by ID and if they are responsive to intravenous iron. METHODS AND RESULTS: Forty-four chronic HF subjects and 25 similar healthy volunteers underwent 31P magnetic resonance spectroscopy of calf muscle at rest and during exercise (plantar flexions). Results were compared between HF subjects with or without ID. In 13 ID-HF subjects, examinations were repeated 1 month after intravenous ferric carboxymaltose administration (1000 mg). As compared with controls, HF subjects displayed lower resting high-energy phosphate content, lower exercise pH, and slower postexercise PCr recovery. Compared with non-ID HF, ID-HF subjects had lower muscle strength, larger PCr depletion, and more profound intracellular acidosis with exercise, consistent with an earlier metabolic shift to anaerobic glycolysis. The exercise-induced PCr drop strongly correlated with pH change in HF group ( r=-0.71, P<0.001) but not in controls ( r=0.13, P=0.61, interaction: P<0.0001). Short-term iron administration corrected the iron deficit but had no effect on muscle bioenergetics assessed 1 month later. CONCLUSIONS: HF patients display skeletal muscle myopathy that is more severe in those with iron deficiency. The presence of ID is associated with greater acidosis with exercise, which may explain early muscle fatigue. Further study is warranted to identify the strategy to restore iron content in skeletal muscle.
650    _2
$a acidóza $x metabolismus $x patofyziologie $7 D000138
650    _2
$a intravenózní podání $7 D061605
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a studie případů a kontrol $7 D016022
650    12
$a energetický metabolismus $x účinky léků $7 D004734
650    12
$a zátěžový test $7 D005080
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a železité sloučeniny $x aplikace a dávkování $7 D005290
650    _2
$a srdeční selhání $x diagnóza $x farmakoterapie $x metabolismus $x patofyziologie $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a železo $x krev $7 D007501
650    12
$a isometrická kontrakce $7 D007537
650    _2
$a bérec $7 D007866
650    _2
$a magnetická rezonanční spektroskopie $x metody $7 D009682
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a maltosa $x aplikace a dávkování $x analogy a deriváty $7 D008320
650    _2
$a lidé středního věku $7 D008875
650    _2
$a kosterní svaly $x účinky léků $x metabolismus $x patofyziologie $7 D018482
650    12
$a izotopy fosforu $7 D010759
650    _2
$a prediktivní hodnota testů $7 D011237
650    _2
$a časové faktory $7 D013997
650    _2
$a výsledek terapie $7 D016896
650    _2
$a deficit železa $7 D000090463
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Extramural $7 D052061
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Hlavata, Katerina $u Department of Cardiology, Institute for Clinical and Experimental Medicine, IKEM, Prague, Czech Republic (V.M., K.H., J.K.).
700    1_
$a Sedivy, Petr $u Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, IKEM, Prague, Czech Republic (P.S., M.D., M.H.).
700    1_
$a Dezortova, Monika $u Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, IKEM, Prague, Czech Republic (P.S., M.D., M.H.).
700    1_
$a Borlaug, Barry A $u Department of Cardiovascular Disease, Mayo Clinic, Rochester, MN (B.A.B.).
700    1_
$a Petrak, Jiri $u Department of Cardiology, Institute for Clinical and Experimental Medicine, IKEM, Prague, Czech Republic (V.M., K.H., J.K.).
700    1_
$a Kautzner, Josef $u BIOCEV, First Faculty of Medicine, Charles University, Vestec, Czech Republic (J.P.).
700    1_
$a Hajek, Milan $u Diagnostic and Interventional Radiology, Institute for Clinical and Experimental Medicine, IKEM, Prague, Czech Republic (P.S., M.D., M.H.).
773    0_
$w MED00159985 $t Circulation. Heart failure $x 1941-3297 $g Roč. 11, č. 9 (2018), s. e004800
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30354361 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191014100034 $b ABA008
999    __
$a ok $b bmc $g 1451608 $s 1073498
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 11 $c 9 $d e004800 $e - $i 1941-3297 $m Circulation. Heart failure $n Circ Heart Fail $x MED00159985
GRA    __
$a R01 HL128526 $p National Heart, Lung, and Blood Institute $2 United States
GRA    __
$a R01 HL126638 $p National Heart, Lung, and Blood Institute $2 United States
GRA    __
$a U01 HL125205 $p National Heart, Lung, and Blood Institute $2 United States
GRA    __
$a U10 HL110262 $p National Heart, Lung, and Blood Institute $2 United States
GRA    __
$a NV16-27496A $p MZ0
LZP    __
$a Pubmed-20191007

Find record

Citation metrics

Logged in users only

Archiving options